Jamie Walters

Antibody purification is an essential step in producing high-quality antibodies, but there's no one 'right' approach. At evitria, we offer a range of purification services designed to meet the diverse needs of our clients' projects. This includes offering alternative resins to aid protein capture for antibodies without a strong affinity to Protein A. Find out what these are and the methods we use for protein polishing in our blog. If you have any questions, please message me or the rest of the team. With evitria, your project is in safe hands. #AntibodyManufacturing #Antibodies #AntibodyPurification #ProteinCapture

14

𝗟𝗲𝘁'𝘀 𝗳𝗮𝗰𝗲 𝗶𝘁: 𝘁𝗵𝗲 𝗯𝗶𝗼𝘁𝗲𝗰𝗵 𝘄𝗼𝗿𝗹𝗱 𝗶𝗻 𝟮𝟬𝟮𝟰 𝗵𝗮𝘀 𝗯𝗲𝗲𝗻 𝗮 𝗿𝗼𝗹𝗹𝗲𝗿𝗰𝗼𝗮𝘀𝘁𝗲𝗿, 𝗮𝗻𝗱 𝗻𝗼𝘁 𝘁𝗵𝗲 𝗳𝘂𝗻 𝗸𝗶𝗻𝗱. Recently, Gabrielle Masson from Fierce Biotech published 𝗧𝗵𝗲 𝟮𝟬𝟮𝟰 𝗕𝗶𝗼𝘁𝗲𝗰𝗵 𝗚𝗿𝗮𝘃𝗲𝘆𝗮𝗿𝗱, a very interesting (and hard-to-read) article. ➡️ https://lnkd.in/e-4snv9y. It's a harsh reality check that's got us all thinking about the wild ups and downs of our innovative, yet sometimes brutal, #Biotech sector. So, 𝘄𝗵𝗮𝘁'𝘀 𝗯𝗲𝗲𝗻 𝗴𝗶𝘃𝗶𝗻𝗴 𝗯𝗶𝗼𝘁𝗲𝗰𝗵 𝗰𝗼𝗺𝗽𝗮𝗻𝗶𝗲𝘀 𝗻𝗶𝗴𝗵𝘁𝗺𝗮𝗿𝗲𝘀 𝘁𝗵𝗶𝘀 𝘆𝗲𝗮𝗿? As I see, this is the not-so-pretty picture: 1️⃣ 💰 💵 𝙈𝙤𝙣𝙚𝙮/𝙁𝙪𝙣𝙙𝙞𝙣𝙜 ➡️ Promising projects are hitting the brakes hard. 2️⃣ 🏥💉𝘾𝙡𝙞𝙣𝙞𝙘𝙖𝙡 𝙩𝙧𝙞𝙖𝙡𝙨 ➡️ They are still biotech's Achilles' heel. One bad result can spell disaster for smaller players. 3️⃣ ❌📝𝙍𝙚𝙜𝙪𝙡𝙖𝙩𝙤𝙧𝙨 𝙠𝙚𝙚𝙥 𝙢𝙤𝙫𝙞𝙣𝙜 𝙩𝙝𝙚 𝙜𝙤𝙖𝙡𝙥𝙤𝙨𝙩𝙨 ➡️ It's like trying to hit a bullseye on a dartboard that won't sit still. They dominate and control the game. 4️⃣ 👩🏻‍🔬👨🏽‍🔬 𝙏𝙖𝙡𝙚𝙣𝙩 ➡️ Keeping the best minds on board is tougher than ever. 5️⃣ 🧬💊𝗙𝗶𝗲𝗹𝗱/𝘀𝗽𝗲𝗰𝗶𝗮𝗹𝗶𝘁𝘆 ➡️ Some therapeutic areas are more very crowded, too many players to fit into the same space. Standing out is a real challenge. Unfortunately, these shutdowns aren't just statistics📈. They're dreams put on ice, time and years of hard work that have gone up in smoke. It makes me wonder: • How might these biotech struggles impact future medical breakthroughs and how will this affect investment in healthcare innovation? • What could this mean for patients waiting for new treatments? • Is there a way to make the biotech industry more resilient to these boom-and-bust cycles? Maybe the most important, with funding drying up, 𝗵𝗼𝘄 𝗰𝗮𝗻 𝗽𝗿𝗼𝗺𝗶𝘀𝗶𝗻𝗴 𝗯𝗶𝗼𝘁𝗲𝗰𝗵 𝘀𝘁𝗮𝗿𝘁𝘂𝗽𝘀 𝘀𝗲𝗰𝘂𝗿𝗲 𝘁𝗵𝗲 𝗰𝗮𝗽𝗶𝘁𝗮𝗹 𝘁𝗵𝗲𝘆 𝗻𝗲𝗲𝗱 𝘁𝗼 𝘀𝘂𝗿𝘃𝗶𝘃𝗲 𝗮𝗻𝗱 𝘁𝗵𝗿𝗶𝘃𝗲?

3

1 commentaire

Belgian PM De Croo highlights the importance of safeguarding Europe's biotech leadership in the face of US and China competition. With a market cap of €22.8 billion and over 600 companies, Belgium's biotech industry shines as a model for the European Health & Biotech Valley. The EC's new initiatives target enhancing biotechnology and biomanufacturing, pivoting on translating proposals into actionable strategies. Focus areas such as financing, development, production, and talent nurturing are key, mirroring Belgium's rollout of the Health & Biotech Valley strategy. Training hubs like ViTalent, aptaskil, and the EU Biotech Campus play a critical role in addressing the sector's skills deficit. Strengthening the financial ecosystem through consolidated funds, stock markets, and a supportive VC landscape is pivotal for sustaining growth. What a great moment to unite and nurture innovation and leadership in Europe's biotech landscape! 🌍💡Looking forward to it! #Biotech #Innovation #Europe #Belgium #Healthcare #Biomanufacturing #VC #TalentDevelopment

9

It is 2024 and we need better ways to deal with protein data than PDB files. I have extensively described the issues with PDB files in this article https://lnkd.in/d-B8atDh If you are looking for a better alternative to work with protein structure data, try the Prot file format. There are many utilities in Protkit to create Prot files and to convert between Prot and other files. Please give Protkit a ⭐ Star ⭐ on GitHub! https://lnkd.in/dcz8sQW9

2

Lipids are more than building blocks—they can influence stability, functionality, and drug delivery performance. Avanti Research released a blog that discusses different lipid morphologies, exploring how their unique structures impact critical applications, from liposomes and micelles to GUVs and more. Whether you're a seasoned researcher or new to the lipid world, understanding these morphologies is key to pushing the boundaries of innovation. Read more about how lipid shape meets function in drug delivery and research: https://ow.ly/GjkV30sITmZ #LipidResearch #DrugDelivery #PharmaceuticalDevelopment #AvantiResearch

13

Struggling to grow your cells in flasks but don't know where to start with bioreactors? Then we have the perfect webinar for you next Thursday. If the timeslot doesn't work for you then no problem, you'll be able to watch the recording on catch up. Full details below

8

The continuous biomanufacturing process has very high yields equivalent to about 30 g/L compared to titers for batch fed single use bioreactors or bags.

1

Amolyt is a perfect example of the companies that we seek to support – a high quality European business that is developing innovative products addressing significant unmet need. We are delighted to have had the opportunity to contribute to the success of Amolyt, and wish Thierry Abribat and the Amolyt team every success in the future. Amolyt Pharma, previously a portfolio company of the ICG Life Sciences team, is now part of AstraZeneca. The transaction – for up to $1.05bn in total consideration – was announced in March. 🔗 Read AstraZeneca announcement: https://lnkd.in/eBDk8t2P Capital at risk. Past performance is not a reliable indicator of future results. #LifeSciences #BioTech #Pharma #Healthcare #Biotechnology #RareDiseases #Endocrine #Hypoparathyroidism #Acromegaly #PrivateMarkets #Alternatives #PrivateCapital #Alts

69

2 commentaires

Compounds containing phosphorus are important across agriculture, pharmaceuticals, clean energy and chemical industries. This new applications note, addresses how benchtop ³¹P NMR spectroscopy characterises phosphorus-containing compounds through their lifecycle with case studies including: ✔️ Detecting oxidation and degradation of raw materials ✔️ Analysis of small nucleoside APIs for drug development ✔️ Monitoring battery electrolyte quality and degradation ✔️ Improving chemical synthesis processes Here's the link to download: https://okt.to/d3ipRQ #drugdevelopment #Spectroscopy #batteries #analyticalchemistry

11

👀 If you missed the #EndOfYearSale of our Advanced Chemical Profiling solution OR you have no idea what I'm talking about, check this out: State-of-the-art automation software for identifying and quantifying substances in pure form or mixtures with the new NMR-based Advanced Chemical Profiling software 👇 #NMR #NMRchat #IndustrialAutomation

7

When I first started working in a cell biology lab, I was shocked to learn that you had to guess cell density to time your experiments. I kept thinking, "Maybe I’m just inexperienced." But after repeating experiments over and over, I realized that wasn’t the problem. It turns out most scientists face the same issue with these estimates, and it’s one of the many reasons so much research isn't reproducible. That’s what sparked the idea behind SnapCyte™—to take the guesswork out of cell culture analysis with AI. If this sounds familiar, check out SnapCyte's whitepaper. It shows how big this problem really is and why it's time to fix it. 👉 [rb.gy/jgzhbm] #AI #CellCulture #Reproducibility #ResearchInnovation #Accuracy #SnapCyte

18

Protein concentration gradients are fundamental to complex life. PODS -formulated protein depots - provide a neat way to study these in the lab.

8

The hidden cost of Noise in workplace Ever noticed how the constant hum of conversation in your QC lab or high decibel manufacturing floor like fermentation area can be distracting? It's not just an annoyance – noise can significantly impact the quality of your work! Research by Nemecek and Grandjean reveals a surprising truth: it's not just the volume of noise that matters, but also the content. During a distracting discussion happening in workplace, a colleague's voice can easily get lost in the background, leading to miscommunication and errors. The High Price of Noise: Communication Breakdowns: Missed instructions or warnings can lead to serious mistakes in procedures. Impaired Focus: Constant noise is a distraction that hinders concentration, causing errors in calculations or measurements. Increased Stress & Fatigue: Prolonged noise exposure can take a toll on overall well-being, making one more prone to errors. Poor Decision-Making: Noise can impair cognitive functions, leading to slower and less accurate judgments in critical situations. This isn't just about working comfort – noise can jeopardize product quality, leading to costly recalls, production delays, and even regulatory non-compliance. Turning Down the Volume on Errors: The good news is that there are effective solutions to mitigate noise in workplace: Engineering Controls: Soundproofing, acoustic panels, and quieter equipment can make a big difference. Administrative Controls: Rotating shifts, providing quiet break areas, and enforcing hearing protection can reduce noise exposure. Personal Protective Equipment: Earplugs or earmuffs offer an added layer of protection in high decibel areas Let's prioritize creating a quieter and more focused working environment to minimize human error and maximize productivity profitability.

1

Many thanks to Eric Jamin from Eurofins Analytics France, for his testimonial! "Our company has been using the NMR Juice-Profiling method since its early days, thus offering our customers the benefit of a wide coverage of authenticity parameters and powerful statistical models. The recent upgrade 4.0, beta-tested in our laboratory, is a significant improvement of the size of the database used and of the range of available models for economically important fruit-producing countries. The presentation of reports is also easier to read for non-experts in the field of NMR profiling. Eurofins Analytics France will continue to support the use of this tool as an efficient authenticity screening approach while offering the community of user laboratories the opportunity to monitor their proficiency through a dedicated Proficiency Testing scheme named PRO-PTS." Eric Jamin Eurofins Analytics France Learn more about Juice-Profiling: https://lnkd.in/dT6sX7gy Eurofins Analyses Alimentaires France #Bruker #MagneticResonance #NMRchat #Testimonial #Juice

28

1 commentaire

Bold and brave by Jubilant Biosys Limited ! 🇮🇳 Perhaps a little misplaced, but ever since the Eli Lilly/Covance Greenfield site deal (can you believe that was 16 years ago?!) I have a certain fondness for this type of agreement, where significant site and domain expertise is not lost in the name of cost control, but instead pivoted from serving the internal needs of a pharma company to face the broader external market as part of a CRO.... ....maybe I'm being idealistic, but beyond the jobs being secured I think I like the sense of parity such deals suggests, that both sponsor and CRO are genuine piers/partners with the shared goal of improving human health driving both sides of the relationship....i.e. in the end, does it really matter which side of the fence you're on?.....(or am I just being a bit romantic....these deals seem to be very popular in France... 🇫🇷 🥂 ) In any case, this seems to me to be a significant deal in that: 1) It brings a serious Indian based Integrated Drug Discovery (IDD) player to the heart of Europe and with a scaled and mature offering. 2) It brings Jubilant straight into the ADC/biologics space, complimenting traditional small molecule expertise. 3) At the flick of a switch it brings new capacity, expertise and capabilities to the European CRO market. In the longer run I guess the challenge will be ensuring that there is sufficient revenue coming to the site if/when Pierre Fabre (inevitably?) scale back once their initial commitment has run down... (as a comparison, GSK committed to $40M over 4 years to Oncodesign Services as part of the deal transferring the Les Ulis site....certainly helps cover the costs for a while...!) But that's a question for tomorrow....for today, congratulations to Giuliano Perfetti and the Jubilant team!

7

Back in 2022, the Life Science Tools market was valued at just over $144B. Fast forward to today, and it’s on track for incredible growth—projected to exceed $360B by 2031 with a CAGR of 10.81%! 📈 𝐖𝐡𝐲 𝐭𝐡𝐞 𝐫𝐚𝐩𝐢𝐝 𝐞𝐱𝐩𝐚𝐧𝐬𝐢𝐨𝐧? 💡 𝐒𝐡𝐢𝐟𝐭 𝐢𝐧 𝐬𝐭𝐫𝐚𝐭𝐞𝐠𝐲: Companies are adapting to reduced external investment, driving more partnerships between Fortune 500s and mid-sized innovators. 💡 𝐃𝐢𝐯𝐞𝐫𝐬𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐬𝐞𝐠𝐦𝐞𝐧𝐭𝐬: Genomics, Proteomics, Cell Biology, Lab Supplies, Analytics & Sample Prep continue to lead the charge. The question is: can this momentum continue? The graph below gives a good indications of the yearly growth expectations. Any thoughts? Feel free to comment below 👇 #LifeSciences #Growth #Biotech

11

I am delighted to announce you that Weo’s research about senescence and anti-aging properties of Weo Water has been published yesterday in the very serious journal Aging (Aging-US) It is the result of our vision on the anti-aging properties of Weo water and of three years of diligent and very high-level research from our team (list below) and directed together with Pierre-Yves Desprez, Director of Research, from the Buck Institute for Research on Aging in #SanFrancisco (leader in #Aging related #research). Here’s an excerpt if you do not wish to read-it all: “… suggests that WEW (Weo Electrolyzed Water) acts as a protective factor, thereby reducing oxidative stress in normal cells, while making cancer cells more sensitive to the effects of cellular stress, thus increasing their elimination and consequently reducing their deleterious effects. These findings suggest that, due to its differential effects as a senomorphic factor, WEW (Weo Electrolyzed Water) could have a positive impact on longevity and age-related diseases.” This very exciting and valuable paper is more than an achievement. It is the demonstration of the incredible properties of our #technology and of the #water Weo is capable of offering. This milestone confirms what I have been claiming since years: aside from its incredible products such as the Weobottle (we-o.com) and a series of products for the BtoB or BtoC markets, Weo is a profound change in the way the world will consume water. This vision is animating Weo’s team to offer a healthier future. Link to the published paper: https://lnkd.in/epY9KURq Proud of our research team on this paper: Brenda Court Vasquez  Shirley Ann Arroyo Dr. Kelly Halderman Lara R Nyman, PhD Jonathan Poli #antiaging #senescence #innovation #Weo #health #biotech #healthtech #watertech #longevity #lifespan  Weo Weo Foundation https://lnkd.in/epY9KURq

54

15 commentaires

The market for bispecific antibodies is growing, creating opportunities for pharma and biotech companies. However, an understanding of bsAbs is required before organisations can start their journey. In this blog post, our own Desmond Schofield explores what bsAbs are, their history, and future prospects for the sector. If you're ready to start exploring the therapeutic potential of these antibodies, the later sections detail how evitria can support you or you can simply get in touch with our team today. #Antibodies #BispecificAntibodies #Biotech #Biopharma

18

1 commentaire